Standout Papers

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B 2006 2026 2012 2019 871
  1. Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B (2006)
    Ching‐Lung Lai, Daniel Shouval et al. New England Journal of Medicine

Immediate Impact

6 by Nobel laureates 8 from Science/Nature 87 standout
Sub-graph 1 of 17

Citing Papers

Type III interferons disrupt the lung epithelial barrier upon viral recognition
2020 StandoutScience
Hepatocellular Carcinoma
2019 Standout
3 intermediate papers

Works of Hugo Cheinquer being referenced

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
2010
Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
2010
and 1 more

Author Peers

Author Last Decade Papers Cites
Hugo Cheinquer 1961 1949 59 189 68 2.1k
F Piccinino 1525 1506 66 169 84 1.7k
Sarah Arterburn 2205 2200 51 388 47 2.6k
Naoky Tsai 1594 1629 32 219 53 1.8k
J. Moussalli 2285 2292 122 130 56 2.6k
Pietro Filippini 1299 1274 41 188 54 1.5k
F. Tremolada 1582 1593 89 111 40 1.8k
Selım Gürel 2670 2706 38 213 46 2.9k
Maria de Medina 1473 1470 72 180 46 1.9k
Y. Benhamou 1220 1258 44 331 60 1.7k
Sarah Blach 2027 1897 90 334 43 2.2k

All Works

Loading papers...

Rankless by CCL
2026